Efficacy And Safety Of Iglarlixi Vs Insulin Glargine 100 U/Ml In Chinese People With Type 2 Diabetes (T2d) Inadequately Controlled On Basal Insulin (Bi): Lixilan-L-China TrialX. Guo,J. Zhang, X. Dong, Y. Lu, W. Pang, S. Gu, L. Ping, G. Nian,E. Niemoeller, E. SouhamiDIABETOLOGIA（2021）引用 1|浏览4暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
